Overview

Ketamine for Depression and Suicide Risk

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study was to find out if the medication known as ketamine could help the symptoms of depression. This drug is approved by the U.S. Food and Drug Administration (FDA) as an anesthetic agent; however, it is not approved for use in depression treatment. The FDA allowed the use of this drug in this research study.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Ketamine